Global Immune Gummies Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Immune Gummies provides immune support. Zinc and Echinacea may support natural resistance. Vitamin D supports healthy teeth and bones.Helps to relieve cold symptoms Everyday immune support With Zinc, Vitamin D and Elderberry.
LPI (LP Information)' newest research report, the “Immune Gummies Industry Forecast” looks at past sales and reviews total world Immune Gummies sales in 2022, providing a comprehensive analysis by region and market sector of projected Immune Gummies sales for 2023 through 2029. With Immune Gummies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immune Gummies industry.
This Insight Report provides a comprehensive analysis of the global Immune Gummies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immune Gummies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Immune Gummies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immune Gummies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immune Gummies.
The global Immune Gummies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Immune Gummies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Immune Gummies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Immune Gummies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Immune Gummies players cover Pfizer Inc, Schiff Vitamins, OLLY Public Benefit Corporation, Alani Nu, Windmill Health Products, Nature's Way Products, Chapter One, Hims, Inc and Sambucol, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Immune Gummies market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Immune Gummies market?
What factors are driving Immune Gummies market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immune Gummies market opportunities vary by end market size?
How does Immune Gummies break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Immune Gummies provides immune support. Zinc and Echinacea may support natural resistance. Vitamin D supports healthy teeth and bones.Helps to relieve cold symptoms Everyday immune support With Zinc, Vitamin D and Elderberry.
LPI (LP Information)' newest research report, the “Immune Gummies Industry Forecast” looks at past sales and reviews total world Immune Gummies sales in 2022, providing a comprehensive analysis by region and market sector of projected Immune Gummies sales for 2023 through 2029. With Immune Gummies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immune Gummies industry.
This Insight Report provides a comprehensive analysis of the global Immune Gummies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immune Gummies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Immune Gummies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immune Gummies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immune Gummies.
The global Immune Gummies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Immune Gummies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Immune Gummies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Immune Gummies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Immune Gummies players cover Pfizer Inc, Schiff Vitamins, OLLY Public Benefit Corporation, Alani Nu, Windmill Health Products, Nature's Way Products, Chapter One, Hims, Inc and Sambucol, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Immune Gummies market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 60-count
- 120-count
- Other
- Online Shopping
- Retailers
- Supermarket
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc
- Schiff Vitamins
- OLLY Public Benefit Corporation
- Alani Nu
- Windmill Health Products
- Nature's Way Products
- Chapter One
- Hims, Inc
- Sambucol
- Jamieson
- Blackmores
- GNC Holdings
What is the 10-year outlook for the global Immune Gummies market?
What factors are driving Immune Gummies market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immune Gummies market opportunities vary by end market size?
How does Immune Gummies break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune Gummies Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Immune Gummies by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Immune Gummies by Country/Region, 2018, 2022 & 2029
2.2 Immune Gummies Segment by Type
2.2.1 60-count
2.2.2 120-count
2.2.3 Other
2.3 Immune Gummies Sales by Type
2.3.1 Global Immune Gummies Sales Market Share by Type (2018-2023)
2.3.2 Global Immune Gummies Revenue and Market Share by Type (2018-2023)
2.3.3 Global Immune Gummies Sale Price by Type (2018-2023)
2.4 Immune Gummies Segment by Application
2.4.1 Online Shopping
2.4.2 Retailers
2.4.3 Supermarket
2.4.4 Other
2.5 Immune Gummies Sales by Application
2.5.1 Global Immune Gummies Sale Market Share by Application (2018-2023)
2.5.2 Global Immune Gummies Revenue and Market Share by Application (2018-2023)
2.5.3 Global Immune Gummies Sale Price by Application (2018-2023)
3 GLOBAL IMMUNE GUMMIES BY COMPANY
3.1 Global Immune Gummies Breakdown Data by Company
3.1.1 Global Immune Gummies Annual Sales by Company (2018-2023)
3.1.2 Global Immune Gummies Sales Market Share by Company (2018-2023)
3.2 Global Immune Gummies Annual Revenue by Company (2018-2023)
3.2.1 Global Immune Gummies Revenue by Company (2018-2023)
3.2.2 Global Immune Gummies Revenue Market Share by Company (2018-2023)
3.3 Global Immune Gummies Sale Price by Company
3.4 Key Manufacturers Immune Gummies Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Gummies Product Location Distribution
3.4.2 Players Immune Gummies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMMUNE GUMMIES BY GEOGRAPHIC REGION
4.1 World Historic Immune Gummies Market Size by Geographic Region (2018-2023)
4.1.1 Global Immune Gummies Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Immune Gummies Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Immune Gummies Market Size by Country/Region (2018-2023)
4.2.1 Global Immune Gummies Annual Sales by Country/Region (2018-2023)
4.2.2 Global Immune Gummies Annual Revenue by Country/Region (2018-2023)
4.3 Americas Immune Gummies Sales Growth
4.4 APAC Immune Gummies Sales Growth
4.5 Europe Immune Gummies Sales Growth
4.6 Middle East & Africa Immune Gummies Sales Growth
5 AMERICAS
5.1 Americas Immune Gummies Sales by Country
5.1.1 Americas Immune Gummies Sales by Country (2018-2023)
5.1.2 Americas Immune Gummies Revenue by Country (2018-2023)
5.2 Americas Immune Gummies Sales by Type
5.3 Americas Immune Gummies Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Gummies Sales by Region
6.1.1 APAC Immune Gummies Sales by Region (2018-2023)
6.1.2 APAC Immune Gummies Revenue by Region (2018-2023)
6.2 APAC Immune Gummies Sales by Type
6.3 APAC Immune Gummies Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immune Gummies by Country
7.1.1 Europe Immune Gummies Sales by Country (2018-2023)
7.1.2 Europe Immune Gummies Revenue by Country (2018-2023)
7.2 Europe Immune Gummies Sales by Type
7.3 Europe Immune Gummies Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune Gummies by Country
8.1.1 Middle East & Africa Immune Gummies Sales by Country (2018-2023)
8.1.2 Middle East & Africa Immune Gummies Revenue by Country (2018-2023)
8.2 Middle East & Africa Immune Gummies Sales by Type
8.3 Middle East & Africa Immune Gummies Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Gummies
10.3 Manufacturing Process Analysis of Immune Gummies
10.4 Industry Chain Structure of Immune Gummies
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Gummies Distributors
11.3 Immune Gummies Customer
12 WORLD FORECAST REVIEW FOR IMMUNE GUMMIES BY GEOGRAPHIC REGION
12.1 Global Immune Gummies Market Size Forecast by Region
12.1.1 Global Immune Gummies Forecast by Region (2024-2029)
12.1.2 Global Immune Gummies Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immune Gummies Forecast by Type
12.7 Global Immune Gummies Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc
13.1.1 Pfizer Inc Company Information
13.1.2 Pfizer Inc Immune Gummies Product Portfolios and Specifications
13.1.3 Pfizer Inc Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Inc Main Business Overview
13.1.5 Pfizer Inc Latest Developments
13.2 Schiff Vitamins
13.2.1 Schiff Vitamins Company Information
13.2.2 Schiff Vitamins Immune Gummies Product Portfolios and Specifications
13.2.3 Schiff Vitamins Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Schiff Vitamins Main Business Overview
13.2.5 Schiff Vitamins Latest Developments
13.3 OLLY Public Benefit Corporation
13.3.1 OLLY Public Benefit Corporation Company Information
13.3.2 OLLY Public Benefit Corporation Immune Gummies Product Portfolios and Specifications
13.3.3 OLLY Public Benefit Corporation Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 OLLY Public Benefit Corporation Main Business Overview
13.3.5 OLLY Public Benefit Corporation Latest Developments
13.4 Alani Nu
13.4.1 Alani Nu Company Information
13.4.2 Alani Nu Immune Gummies Product Portfolios and Specifications
13.4.3 Alani Nu Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Alani Nu Main Business Overview
13.4.5 Alani Nu Latest Developments
13.5 Windmill Health Products
13.5.1 Windmill Health Products Company Information
13.5.2 Windmill Health Products Immune Gummies Product Portfolios and Specifications
13.5.3 Windmill Health Products Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Windmill Health Products Main Business Overview
13.5.5 Windmill Health Products Latest Developments
13.6 Nature's Way Products
13.6.1 Nature's Way Products Company Information
13.6.2 Nature's Way Products Immune Gummies Product Portfolios and Specifications
13.6.3 Nature's Way Products Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nature's Way Products Main Business Overview
13.6.5 Nature's Way Products Latest Developments
13.7 Chapter One
13.7.1 Chapter One Company Information
13.7.2 Chapter One Immune Gummies Product Portfolios and Specifications
13.7.3 Chapter One Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chapter One Main Business Overview
13.7.5 Chapter One Latest Developments
13.8 Hims, Inc
13.8.1 Hims, Inc Company Information
13.8.2 Hims, Inc Immune Gummies Product Portfolios and Specifications
13.8.3 Hims, Inc Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hims, Inc Main Business Overview
13.8.5 Hims, Inc Latest Developments
13.9 Sambucol
13.9.1 Sambucol Company Information
13.9.2 Sambucol Immune Gummies Product Portfolios and Specifications
13.9.3 Sambucol Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sambucol Main Business Overview
13.9.5 Sambucol Latest Developments
13.10 Jamieson
13.10.1 Jamieson Company Information
13.10.2 Jamieson Immune Gummies Product Portfolios and Specifications
13.10.3 Jamieson Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jamieson Main Business Overview
13.10.5 Jamieson Latest Developments
13.11 Blackmores
13.11.1 Blackmores Company Information
13.11.2 Blackmores Immune Gummies Product Portfolios and Specifications
13.11.3 Blackmores Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Blackmores Main Business Overview
13.11.5 Blackmores Latest Developments
13.12 GNC Holdings
13.12.1 GNC Holdings Company Information
13.12.2 GNC Holdings Immune Gummies Product Portfolios and Specifications
13.12.3 GNC Holdings Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 GNC Holdings Main Business Overview
13.12.5 GNC Holdings Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune Gummies Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Immune Gummies by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Immune Gummies by Country/Region, 2018, 2022 & 2029
2.2 Immune Gummies Segment by Type
2.2.1 60-count
2.2.2 120-count
2.2.3 Other
2.3 Immune Gummies Sales by Type
2.3.1 Global Immune Gummies Sales Market Share by Type (2018-2023)
2.3.2 Global Immune Gummies Revenue and Market Share by Type (2018-2023)
2.3.3 Global Immune Gummies Sale Price by Type (2018-2023)
2.4 Immune Gummies Segment by Application
2.4.1 Online Shopping
2.4.2 Retailers
2.4.3 Supermarket
2.4.4 Other
2.5 Immune Gummies Sales by Application
2.5.1 Global Immune Gummies Sale Market Share by Application (2018-2023)
2.5.2 Global Immune Gummies Revenue and Market Share by Application (2018-2023)
2.5.3 Global Immune Gummies Sale Price by Application (2018-2023)
3 GLOBAL IMMUNE GUMMIES BY COMPANY
3.1 Global Immune Gummies Breakdown Data by Company
3.1.1 Global Immune Gummies Annual Sales by Company (2018-2023)
3.1.2 Global Immune Gummies Sales Market Share by Company (2018-2023)
3.2 Global Immune Gummies Annual Revenue by Company (2018-2023)
3.2.1 Global Immune Gummies Revenue by Company (2018-2023)
3.2.2 Global Immune Gummies Revenue Market Share by Company (2018-2023)
3.3 Global Immune Gummies Sale Price by Company
3.4 Key Manufacturers Immune Gummies Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Gummies Product Location Distribution
3.4.2 Players Immune Gummies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMMUNE GUMMIES BY GEOGRAPHIC REGION
4.1 World Historic Immune Gummies Market Size by Geographic Region (2018-2023)
4.1.1 Global Immune Gummies Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Immune Gummies Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Immune Gummies Market Size by Country/Region (2018-2023)
4.2.1 Global Immune Gummies Annual Sales by Country/Region (2018-2023)
4.2.2 Global Immune Gummies Annual Revenue by Country/Region (2018-2023)
4.3 Americas Immune Gummies Sales Growth
4.4 APAC Immune Gummies Sales Growth
4.5 Europe Immune Gummies Sales Growth
4.6 Middle East & Africa Immune Gummies Sales Growth
5 AMERICAS
5.1 Americas Immune Gummies Sales by Country
5.1.1 Americas Immune Gummies Sales by Country (2018-2023)
5.1.2 Americas Immune Gummies Revenue by Country (2018-2023)
5.2 Americas Immune Gummies Sales by Type
5.3 Americas Immune Gummies Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Gummies Sales by Region
6.1.1 APAC Immune Gummies Sales by Region (2018-2023)
6.1.2 APAC Immune Gummies Revenue by Region (2018-2023)
6.2 APAC Immune Gummies Sales by Type
6.3 APAC Immune Gummies Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immune Gummies by Country
7.1.1 Europe Immune Gummies Sales by Country (2018-2023)
7.1.2 Europe Immune Gummies Revenue by Country (2018-2023)
7.2 Europe Immune Gummies Sales by Type
7.3 Europe Immune Gummies Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune Gummies by Country
8.1.1 Middle East & Africa Immune Gummies Sales by Country (2018-2023)
8.1.2 Middle East & Africa Immune Gummies Revenue by Country (2018-2023)
8.2 Middle East & Africa Immune Gummies Sales by Type
8.3 Middle East & Africa Immune Gummies Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Gummies
10.3 Manufacturing Process Analysis of Immune Gummies
10.4 Industry Chain Structure of Immune Gummies
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Gummies Distributors
11.3 Immune Gummies Customer
12 WORLD FORECAST REVIEW FOR IMMUNE GUMMIES BY GEOGRAPHIC REGION
12.1 Global Immune Gummies Market Size Forecast by Region
12.1.1 Global Immune Gummies Forecast by Region (2024-2029)
12.1.2 Global Immune Gummies Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immune Gummies Forecast by Type
12.7 Global Immune Gummies Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc
13.1.1 Pfizer Inc Company Information
13.1.2 Pfizer Inc Immune Gummies Product Portfolios and Specifications
13.1.3 Pfizer Inc Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Inc Main Business Overview
13.1.5 Pfizer Inc Latest Developments
13.2 Schiff Vitamins
13.2.1 Schiff Vitamins Company Information
13.2.2 Schiff Vitamins Immune Gummies Product Portfolios and Specifications
13.2.3 Schiff Vitamins Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Schiff Vitamins Main Business Overview
13.2.5 Schiff Vitamins Latest Developments
13.3 OLLY Public Benefit Corporation
13.3.1 OLLY Public Benefit Corporation Company Information
13.3.2 OLLY Public Benefit Corporation Immune Gummies Product Portfolios and Specifications
13.3.3 OLLY Public Benefit Corporation Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 OLLY Public Benefit Corporation Main Business Overview
13.3.5 OLLY Public Benefit Corporation Latest Developments
13.4 Alani Nu
13.4.1 Alani Nu Company Information
13.4.2 Alani Nu Immune Gummies Product Portfolios and Specifications
13.4.3 Alani Nu Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Alani Nu Main Business Overview
13.4.5 Alani Nu Latest Developments
13.5 Windmill Health Products
13.5.1 Windmill Health Products Company Information
13.5.2 Windmill Health Products Immune Gummies Product Portfolios and Specifications
13.5.3 Windmill Health Products Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Windmill Health Products Main Business Overview
13.5.5 Windmill Health Products Latest Developments
13.6 Nature's Way Products
13.6.1 Nature's Way Products Company Information
13.6.2 Nature's Way Products Immune Gummies Product Portfolios and Specifications
13.6.3 Nature's Way Products Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nature's Way Products Main Business Overview
13.6.5 Nature's Way Products Latest Developments
13.7 Chapter One
13.7.1 Chapter One Company Information
13.7.2 Chapter One Immune Gummies Product Portfolios and Specifications
13.7.3 Chapter One Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chapter One Main Business Overview
13.7.5 Chapter One Latest Developments
13.8 Hims, Inc
13.8.1 Hims, Inc Company Information
13.8.2 Hims, Inc Immune Gummies Product Portfolios and Specifications
13.8.3 Hims, Inc Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hims, Inc Main Business Overview
13.8.5 Hims, Inc Latest Developments
13.9 Sambucol
13.9.1 Sambucol Company Information
13.9.2 Sambucol Immune Gummies Product Portfolios and Specifications
13.9.3 Sambucol Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sambucol Main Business Overview
13.9.5 Sambucol Latest Developments
13.10 Jamieson
13.10.1 Jamieson Company Information
13.10.2 Jamieson Immune Gummies Product Portfolios and Specifications
13.10.3 Jamieson Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jamieson Main Business Overview
13.10.5 Jamieson Latest Developments
13.11 Blackmores
13.11.1 Blackmores Company Information
13.11.2 Blackmores Immune Gummies Product Portfolios and Specifications
13.11.3 Blackmores Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Blackmores Main Business Overview
13.11.5 Blackmores Latest Developments
13.12 GNC Holdings
13.12.1 GNC Holdings Company Information
13.12.2 GNC Holdings Immune Gummies Product Portfolios and Specifications
13.12.3 GNC Holdings Immune Gummies Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 GNC Holdings Main Business Overview
13.12.5 GNC Holdings Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immune Gummies Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Immune Gummies Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 60-count
Table 4. Major Players of 120-count
Table 5. Major Players of Other
Table 6. Global Immune Gummies Sales by Type (2018-2023) & (MT)
Table 7. Global Immune Gummies Sales Market Share by Type (2018-2023)
Table 8. Global Immune Gummies Revenue by Type (2018-2023) & ($ million)
Table 9. Global Immune Gummies Revenue Market Share by Type (2018-2023)
Table 10. Global Immune Gummies Sale Price by Type (2018-2023) & (US$/Kg)
Table 11. Global Immune Gummies Sales by Application (2018-2023) & (MT)
Table 12. Global Immune Gummies Sales Market Share by Application (2018-2023)
Table 13. Global Immune Gummies Revenue by Application (2018-2023)
Table 14. Global Immune Gummies Revenue Market Share by Application (2018-2023)
Table 15. Global Immune Gummies Sale Price by Application (2018-2023) & (US$/Kg)
Table 16. Global Immune Gummies Sales by Company (2018-2023) & (MT)
Table 17. Global Immune Gummies Sales Market Share by Company (2018-2023)
Table 18. Global Immune Gummies Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Immune Gummies Revenue Market Share by Company (2018-2023)
Table 20. Global Immune Gummies Sale Price by Company (2018-2023) & (US$/Kg)
Table 21. Key Manufacturers Immune Gummies Producing Area Distribution and Sales Area
Table 22. Players Immune Gummies Products Offered
Table 23. Immune Gummies Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Immune Gummies Sales by Geographic Region (2018-2023) & (MT)
Table 27. Global Immune Gummies Sales Market Share Geographic Region (2018-2023)
Table 28. Global Immune Gummies Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Immune Gummies Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Immune Gummies Sales by Country/Region (2018-2023) & (MT)
Table 31. Global Immune Gummies Sales Market Share by Country/Region (2018-2023)
Table 32. Global Immune Gummies Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Immune Gummies Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Immune Gummies Sales by Country (2018-2023) & (MT)
Table 35. Americas Immune Gummies Sales Market Share by Country (2018-2023)
Table 36. Americas Immune Gummies Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Immune Gummies Revenue Market Share by Country (2018-2023)
Table 38. Americas Immune Gummies Sales by Type (2018-2023) & (MT)
Table 39. Americas Immune Gummies Sales by Application (2018-2023) & (MT)
Table 40. APAC Immune Gummies Sales by Region (2018-2023) & (MT)
Table 41. APAC Immune Gummies Sales Market Share by Region (2018-2023)
Table 42. APAC Immune Gummies Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Immune Gummies Revenue Market Share by Region (2018-2023)
Table 44. APAC Immune Gummies Sales by Type (2018-2023) & (MT)
Table 45. APAC Immune Gummies Sales by Application (2018-2023) & (MT)
Table 46. Europe Immune Gummies Sales by Country (2018-2023) & (MT)
Table 47. Europe Immune Gummies Sales Market Share by Country (2018-2023)
Table 48. Europe Immune Gummies Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Immune Gummies Revenue Market Share by Country (2018-2023)
Table 50. Europe Immune Gummies Sales by Type (2018-2023) & (MT)
Table 51. Europe Immune Gummies Sales by Application (2018-2023) & (MT)
Table 52. Middle East & Africa Immune Gummies Sales by Country (2018-2023) & (MT)
Table 53. Middle East & Africa Immune Gummies Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Immune Gummies Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Immune Gummies Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Immune Gummies Sales by Type (2018-2023) & (MT)
Table 57. Middle East & Africa Immune Gummies Sales by Application (2018-2023) & (MT)
Table 58. Key Market Drivers & Growth Opportunities of Immune Gummies
Table 59. Key Market Challenges & Risks of Immune Gummies
Table 60. Key Industry Trends of Immune Gummies
Table 61. Immune Gummies Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Immune Gummies Distributors List
Table 64. Immune Gummies Customer List
Table 65. Global Immune Gummies Sales Forecast by Region (2024-2029) & (MT)
Table 66. Global Immune Gummies Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Immune Gummies Sales Forecast by Country (2024-2029) & (MT)
Table 68. Americas Immune Gummies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Immune Gummies Sales Forecast by Region (2024-2029) & (MT)
Table 70. APAC Immune Gummies Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Immune Gummies Sales Forecast by Country (2024-2029) & (MT)
Table 72. Europe Immune Gummies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Immune Gummies Sales Forecast by Country (2024-2029) & (MT)
Table 74. Middle East & Africa Immune Gummies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Immune Gummies Sales Forecast by Type (2024-2029) & (MT)
Table 76. Global Immune Gummies Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Immune Gummies Sales Forecast by Application (2024-2029) & (MT)
Table 78. Global Immune Gummies Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Inc Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Inc Immune Gummies Product Portfolios and Specifications
Table 81. Pfizer Inc Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 82. Pfizer Inc Main Business
Table 83. Pfizer Inc Latest Developments
Table 84. Schiff Vitamins Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 85. Schiff Vitamins Immune Gummies Product Portfolios and Specifications
Table 86. Schiff Vitamins Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 87. Schiff Vitamins Main Business
Table 88. Schiff Vitamins Latest Developments
Table 89. OLLY Public Benefit Corporation Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 90. OLLY Public Benefit Corporation Immune Gummies Product Portfolios and Specifications
Table 91. OLLY Public Benefit Corporation Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 92. OLLY Public Benefit Corporation Main Business
Table 93. OLLY Public Benefit Corporation Latest Developments
Table 94. Alani Nu Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 95. Alani Nu Immune Gummies Product Portfolios and Specifications
Table 96. Alani Nu Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 97. Alani Nu Main Business
Table 98. Alani Nu Latest Developments
Table 99. Windmill Health Products Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 100. Windmill Health Products Immune Gummies Product Portfolios and Specifications
Table 101. Windmill Health Products Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 102. Windmill Health Products Main Business
Table 103. Windmill Health Products Latest Developments
Table 104. Nature's Way Products Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 105. Nature's Way Products Immune Gummies Product Portfolios and Specifications
Table 106. Nature's Way Products Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 107. Nature's Way Products Main Business
Table 108. Nature's Way Products Latest Developments
Table 109. Chapter One Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 110. Chapter One Immune Gummies Product Portfolios and Specifications
Table 111. Chapter One Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 112. Chapter One Main Business
Table 113. Chapter One Latest Developments
Table 114. Hims, Inc Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 115. Hims, Inc Immune Gummies Product Portfolios and Specifications
Table 116. Hims, Inc Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 117. Hims, Inc Main Business
Table 118. Hims, Inc Latest Developments
Table 119. Sambucol Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 120. Sambucol Immune Gummies Product Portfolios and Specifications
Table 121. Sambucol Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 122. Sambucol Main Business
Table 123. Sambucol Latest Developments
Table 124. Jamieson Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 125. Jamieson Immune Gummies Product Portfolios and Specifications
Table 126. Jamieson Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 127. Jamieson Main Business
Table 128. Jamieson Latest Developments
Table 129. Blackmores Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 130. Blackmores Immune Gummies Product Portfolios and Specifications
Table 131. Blackmores Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 132. Blackmores Main Business
Table 133. Blackmores Latest Developments
Table 134. GNC Holdings Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 135. GNC Holdings Immune Gummies Product Portfolios and Specifications
Table 136. GNC Holdings Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 137. GNC Holdings Main Business
Table 138. GNC Holdings Latest Developments
Table 1. Immune Gummies Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Immune Gummies Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 60-count
Table 4. Major Players of 120-count
Table 5. Major Players of Other
Table 6. Global Immune Gummies Sales by Type (2018-2023) & (MT)
Table 7. Global Immune Gummies Sales Market Share by Type (2018-2023)
Table 8. Global Immune Gummies Revenue by Type (2018-2023) & ($ million)
Table 9. Global Immune Gummies Revenue Market Share by Type (2018-2023)
Table 10. Global Immune Gummies Sale Price by Type (2018-2023) & (US$/Kg)
Table 11. Global Immune Gummies Sales by Application (2018-2023) & (MT)
Table 12. Global Immune Gummies Sales Market Share by Application (2018-2023)
Table 13. Global Immune Gummies Revenue by Application (2018-2023)
Table 14. Global Immune Gummies Revenue Market Share by Application (2018-2023)
Table 15. Global Immune Gummies Sale Price by Application (2018-2023) & (US$/Kg)
Table 16. Global Immune Gummies Sales by Company (2018-2023) & (MT)
Table 17. Global Immune Gummies Sales Market Share by Company (2018-2023)
Table 18. Global Immune Gummies Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Immune Gummies Revenue Market Share by Company (2018-2023)
Table 20. Global Immune Gummies Sale Price by Company (2018-2023) & (US$/Kg)
Table 21. Key Manufacturers Immune Gummies Producing Area Distribution and Sales Area
Table 22. Players Immune Gummies Products Offered
Table 23. Immune Gummies Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Immune Gummies Sales by Geographic Region (2018-2023) & (MT)
Table 27. Global Immune Gummies Sales Market Share Geographic Region (2018-2023)
Table 28. Global Immune Gummies Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Immune Gummies Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Immune Gummies Sales by Country/Region (2018-2023) & (MT)
Table 31. Global Immune Gummies Sales Market Share by Country/Region (2018-2023)
Table 32. Global Immune Gummies Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Immune Gummies Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Immune Gummies Sales by Country (2018-2023) & (MT)
Table 35. Americas Immune Gummies Sales Market Share by Country (2018-2023)
Table 36. Americas Immune Gummies Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Immune Gummies Revenue Market Share by Country (2018-2023)
Table 38. Americas Immune Gummies Sales by Type (2018-2023) & (MT)
Table 39. Americas Immune Gummies Sales by Application (2018-2023) & (MT)
Table 40. APAC Immune Gummies Sales by Region (2018-2023) & (MT)
Table 41. APAC Immune Gummies Sales Market Share by Region (2018-2023)
Table 42. APAC Immune Gummies Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Immune Gummies Revenue Market Share by Region (2018-2023)
Table 44. APAC Immune Gummies Sales by Type (2018-2023) & (MT)
Table 45. APAC Immune Gummies Sales by Application (2018-2023) & (MT)
Table 46. Europe Immune Gummies Sales by Country (2018-2023) & (MT)
Table 47. Europe Immune Gummies Sales Market Share by Country (2018-2023)
Table 48. Europe Immune Gummies Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Immune Gummies Revenue Market Share by Country (2018-2023)
Table 50. Europe Immune Gummies Sales by Type (2018-2023) & (MT)
Table 51. Europe Immune Gummies Sales by Application (2018-2023) & (MT)
Table 52. Middle East & Africa Immune Gummies Sales by Country (2018-2023) & (MT)
Table 53. Middle East & Africa Immune Gummies Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Immune Gummies Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Immune Gummies Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Immune Gummies Sales by Type (2018-2023) & (MT)
Table 57. Middle East & Africa Immune Gummies Sales by Application (2018-2023) & (MT)
Table 58. Key Market Drivers & Growth Opportunities of Immune Gummies
Table 59. Key Market Challenges & Risks of Immune Gummies
Table 60. Key Industry Trends of Immune Gummies
Table 61. Immune Gummies Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Immune Gummies Distributors List
Table 64. Immune Gummies Customer List
Table 65. Global Immune Gummies Sales Forecast by Region (2024-2029) & (MT)
Table 66. Global Immune Gummies Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Immune Gummies Sales Forecast by Country (2024-2029) & (MT)
Table 68. Americas Immune Gummies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Immune Gummies Sales Forecast by Region (2024-2029) & (MT)
Table 70. APAC Immune Gummies Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Immune Gummies Sales Forecast by Country (2024-2029) & (MT)
Table 72. Europe Immune Gummies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Immune Gummies Sales Forecast by Country (2024-2029) & (MT)
Table 74. Middle East & Africa Immune Gummies Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Immune Gummies Sales Forecast by Type (2024-2029) & (MT)
Table 76. Global Immune Gummies Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Immune Gummies Sales Forecast by Application (2024-2029) & (MT)
Table 78. Global Immune Gummies Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Inc Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Inc Immune Gummies Product Portfolios and Specifications
Table 81. Pfizer Inc Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 82. Pfizer Inc Main Business
Table 83. Pfizer Inc Latest Developments
Table 84. Schiff Vitamins Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 85. Schiff Vitamins Immune Gummies Product Portfolios and Specifications
Table 86. Schiff Vitamins Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 87. Schiff Vitamins Main Business
Table 88. Schiff Vitamins Latest Developments
Table 89. OLLY Public Benefit Corporation Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 90. OLLY Public Benefit Corporation Immune Gummies Product Portfolios and Specifications
Table 91. OLLY Public Benefit Corporation Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 92. OLLY Public Benefit Corporation Main Business
Table 93. OLLY Public Benefit Corporation Latest Developments
Table 94. Alani Nu Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 95. Alani Nu Immune Gummies Product Portfolios and Specifications
Table 96. Alani Nu Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 97. Alani Nu Main Business
Table 98. Alani Nu Latest Developments
Table 99. Windmill Health Products Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 100. Windmill Health Products Immune Gummies Product Portfolios and Specifications
Table 101. Windmill Health Products Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 102. Windmill Health Products Main Business
Table 103. Windmill Health Products Latest Developments
Table 104. Nature's Way Products Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 105. Nature's Way Products Immune Gummies Product Portfolios and Specifications
Table 106. Nature's Way Products Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 107. Nature's Way Products Main Business
Table 108. Nature's Way Products Latest Developments
Table 109. Chapter One Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 110. Chapter One Immune Gummies Product Portfolios and Specifications
Table 111. Chapter One Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 112. Chapter One Main Business
Table 113. Chapter One Latest Developments
Table 114. Hims, Inc Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 115. Hims, Inc Immune Gummies Product Portfolios and Specifications
Table 116. Hims, Inc Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 117. Hims, Inc Main Business
Table 118. Hims, Inc Latest Developments
Table 119. Sambucol Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 120. Sambucol Immune Gummies Product Portfolios and Specifications
Table 121. Sambucol Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 122. Sambucol Main Business
Table 123. Sambucol Latest Developments
Table 124. Jamieson Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 125. Jamieson Immune Gummies Product Portfolios and Specifications
Table 126. Jamieson Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 127. Jamieson Main Business
Table 128. Jamieson Latest Developments
Table 129. Blackmores Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 130. Blackmores Immune Gummies Product Portfolios and Specifications
Table 131. Blackmores Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 132. Blackmores Main Business
Table 133. Blackmores Latest Developments
Table 134. GNC Holdings Basic Information, Immune Gummies Manufacturing Base, Sales Area and Its Competitors
Table 135. GNC Holdings Immune Gummies Product Portfolios and Specifications
Table 136. GNC Holdings Immune Gummies Sales (MT), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 137. GNC Holdings Main Business
Table 138. GNC Holdings Latest Developments
LIST OF FIGURES
Figure 1. Picture of Immune Gummies
Figure 2. Immune Gummies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immune Gummies Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Immune Gummies Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Immune Gummies Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 60-count
Figure 10. Product Picture of 120-count
Figure 11. Product Picture of Other
Figure 12. Global Immune Gummies Sales Market Share by Type in 2022
Figure 13. Global Immune Gummies Revenue Market Share by Type (2018-2023)
Figure 14. Immune Gummies Consumed in Online Shopping
Figure 15. Global Immune Gummies Market: Online Shopping (2018-2023) & (MT)
Figure 16. Immune Gummies Consumed in Retailers
Figure 17. Global Immune Gummies Market: Retailers (2018-2023) & (MT)
Figure 18. Immune Gummies Consumed in Supermarket
Figure 19. Global Immune Gummies Market: Supermarket (2018-2023) & (MT)
Figure 20. Immune Gummies Consumed in Other
Figure 21. Global Immune Gummies Market: Other (2018-2023) & (MT)
Figure 22. Global Immune Gummies Sales Market Share by Application (2022)
Figure 23. Global Immune Gummies Revenue Market Share by Application in 2022
Figure 24. Immune Gummies Sales Market by Company in 2022 (MT)
Figure 25. Global Immune Gummies Sales Market Share by Company in 2022
Figure 26. Immune Gummies Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Immune Gummies Revenue Market Share by Company in 2022
Figure 28. Global Immune Gummies Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Immune Gummies Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Immune Gummies Sales 2018-2023 (MT)
Figure 31. Americas Immune Gummies Revenue 2018-2023 ($ Millions)
Figure 32. APAC Immune Gummies Sales 2018-2023 (MT)
Figure 33. APAC Immune Gummies Revenue 2018-2023 ($ Millions)
Figure 34. Europe Immune Gummies Sales 2018-2023 (MT)
Figure 35. Europe Immune Gummies Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Immune Gummies Sales 2018-2023 (MT)
Figure 37. Middle East & Africa Immune Gummies Revenue 2018-2023 ($ Millions)
Figure 38. Americas Immune Gummies Sales Market Share by Country in 2022
Figure 39. Americas Immune Gummies Revenue Market Share by Country in 2022
Figure 40. Americas Immune Gummies Sales Market Share by Type (2018-2023)
Figure 41. Americas Immune Gummies Sales Market Share by Application (2018-2023)
Figure 42. United States Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Immune Gummies Sales Market Share by Region in 2022
Figure 47. APAC Immune Gummies Revenue Market Share by Regions in 2022
Figure 48. APAC Immune Gummies Sales Market Share by Type (2018-2023)
Figure 49. APAC Immune Gummies Sales Market Share by Application (2018-2023)
Figure 50. China Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Immune Gummies Sales Market Share by Country in 2022
Figure 58. Europe Immune Gummies Revenue Market Share by Country in 2022
Figure 59. Europe Immune Gummies Sales Market Share by Type (2018-2023)
Figure 60. Europe Immune Gummies Sales Market Share by Application (2018-2023)
Figure 61. Germany Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Immune Gummies Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Immune Gummies Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Immune Gummies Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Immune Gummies Sales Market Share by Application (2018-2023)
Figure 70. Egypt Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Immune Gummies in 2022
Figure 76. Manufacturing Process Analysis of Immune Gummies
Figure 77. Industry Chain Structure of Immune Gummies
Figure 78. Channels of Distribution
Figure 79. Global Immune Gummies Sales Market Forecast by Region (2024-2029)
Figure 80. Global Immune Gummies Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Immune Gummies Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Immune Gummies Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Immune Gummies Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Immune Gummies Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Immune Gummies
Figure 2. Immune Gummies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immune Gummies Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Immune Gummies Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Immune Gummies Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 60-count
Figure 10. Product Picture of 120-count
Figure 11. Product Picture of Other
Figure 12. Global Immune Gummies Sales Market Share by Type in 2022
Figure 13. Global Immune Gummies Revenue Market Share by Type (2018-2023)
Figure 14. Immune Gummies Consumed in Online Shopping
Figure 15. Global Immune Gummies Market: Online Shopping (2018-2023) & (MT)
Figure 16. Immune Gummies Consumed in Retailers
Figure 17. Global Immune Gummies Market: Retailers (2018-2023) & (MT)
Figure 18. Immune Gummies Consumed in Supermarket
Figure 19. Global Immune Gummies Market: Supermarket (2018-2023) & (MT)
Figure 20. Immune Gummies Consumed in Other
Figure 21. Global Immune Gummies Market: Other (2018-2023) & (MT)
Figure 22. Global Immune Gummies Sales Market Share by Application (2022)
Figure 23. Global Immune Gummies Revenue Market Share by Application in 2022
Figure 24. Immune Gummies Sales Market by Company in 2022 (MT)
Figure 25. Global Immune Gummies Sales Market Share by Company in 2022
Figure 26. Immune Gummies Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Immune Gummies Revenue Market Share by Company in 2022
Figure 28. Global Immune Gummies Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Immune Gummies Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Immune Gummies Sales 2018-2023 (MT)
Figure 31. Americas Immune Gummies Revenue 2018-2023 ($ Millions)
Figure 32. APAC Immune Gummies Sales 2018-2023 (MT)
Figure 33. APAC Immune Gummies Revenue 2018-2023 ($ Millions)
Figure 34. Europe Immune Gummies Sales 2018-2023 (MT)
Figure 35. Europe Immune Gummies Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Immune Gummies Sales 2018-2023 (MT)
Figure 37. Middle East & Africa Immune Gummies Revenue 2018-2023 ($ Millions)
Figure 38. Americas Immune Gummies Sales Market Share by Country in 2022
Figure 39. Americas Immune Gummies Revenue Market Share by Country in 2022
Figure 40. Americas Immune Gummies Sales Market Share by Type (2018-2023)
Figure 41. Americas Immune Gummies Sales Market Share by Application (2018-2023)
Figure 42. United States Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Immune Gummies Sales Market Share by Region in 2022
Figure 47. APAC Immune Gummies Revenue Market Share by Regions in 2022
Figure 48. APAC Immune Gummies Sales Market Share by Type (2018-2023)
Figure 49. APAC Immune Gummies Sales Market Share by Application (2018-2023)
Figure 50. China Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Immune Gummies Sales Market Share by Country in 2022
Figure 58. Europe Immune Gummies Revenue Market Share by Country in 2022
Figure 59. Europe Immune Gummies Sales Market Share by Type (2018-2023)
Figure 60. Europe Immune Gummies Sales Market Share by Application (2018-2023)
Figure 61. Germany Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Immune Gummies Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Immune Gummies Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Immune Gummies Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Immune Gummies Sales Market Share by Application (2018-2023)
Figure 70. Egypt Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Immune Gummies Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Immune Gummies in 2022
Figure 76. Manufacturing Process Analysis of Immune Gummies
Figure 77. Industry Chain Structure of Immune Gummies
Figure 78. Channels of Distribution
Figure 79. Global Immune Gummies Sales Market Forecast by Region (2024-2029)
Figure 80. Global Immune Gummies Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Immune Gummies Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Immune Gummies Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Immune Gummies Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Immune Gummies Revenue Market Share Forecast by Application (2024-2029)
